Institution Information
Reportee Signature Date Report period Total Entries Total AUM($)
VERSANT VENTURE MANAGEMENT LLC 04-27-2020 03-31-2020 9 364,636,407
Institutional Holdings
Issuer Class Position Value Shares Portfolio Percentage (%) Previous Percentage (%) Shares Delta Shares Delta(%) Date Reported
CRISPR Therapeutics AG Common Stock 1 $177,224,616 4,205,615 0.05 0.08 0 0.00 03-31-2020
Adverum Biotechnologies, Inc. Common Stock 2 $69,056,636 7,068,233 0.02 7,068,233 +Inf 03-31-2020
Akero Therapeutics, Inc. Common Stock 3 $58,015,326 2,736,572 0.02 2,736,572 +Inf 03-31-2020
Veracyte, Inc. Common Stock 4 $29,303,444 1,205,407 0.01 0.01 0 0.00 03-31-2020
logo   

Please login to see all results. Signup if you don't have an account.

Login Signup
Debug Info- Version: 2.4